| 680 | For the treatment of severe plaque psoriasis in patients who meet the following criteria:
- Patients who become pregnant during the transition period of July 31, 2024, to January 31, 2025.
|
| | LU Authorization Period: 12 months from date of authorization. |
| 681 | For the treatment of severe plaque psoriasis in patients who meet the following criteria:
- Patients who require palliative care during the transition period of July 31, 2024, to January 31, 2025.
|
| | LU Authorization Period: 12 months from date of authorization. |
